跳至主要内容
临床试验/NCT03571490
NCT03571490已完成4 期

Improving Postoperative Pain Management With the Ultrasound-guided Transmuscular Quadratus Lumborum Block for Elective Laparoscopic Hand-assisted Nephrectomy and Robot-assisted Partiel Nephrectomy: A Double Blind, Randomized, Placebo Controlled Trial

Zealand University Hospital1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2018年6月26日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
入组人数
50
试验地点
1
主要终点
opioid consumption

研究概览

简要总结

Patients with kidney cancer often undergo hand-assisted laparoscopic nephrectomy or Robot assisted partiel nephrectomy. The investigators performed a one-year retrospective study. the sudy revealed that 67% of the patients needed substantial amounts of opioids for postoperative pain management (PPM) in recovery despite a multimodal analgesic regime. In a prospective pilot study including ten laparoscopic hand-assisted nephrectomy, with severe postoperative pain the investigators found that bilateral Ultrasound-guided (USG) transmuscular quadratus lumborum (TQL) block substantially reduced pain and opioid consumption. This study aims to evaluate the effect on PPM of a bilateral USG TQL block compared to placebo.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

盲法说明

Double blind

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • over 18 years
  • Kidney cancer
  • Have received thorough information, orally and in written
  • Signed the "Informed Consent" form on participation in the trial

排除标准

  • Inability to cooperate
  • Inability to speak and understand Danish both orally and written
  • Allergy to local anaesthetics or opioids
  • Daily intake of opioids
  • Local infection at the site of injection or systemic infection
  • Difficulty visualisation of muscular and fascial structures in ultrasound visualisation necessary to the block administration
  • Known abuse of alcohol or medicine
  • Pregnancy

研究组 & 干预措施

TQL Ropivacaine(active)

Active Comparator

Bilateral Single shot of ropivacaine 0.325% 30 mL. In total 60 mL of 0.325% ropivacaine

干预措施: Ropivacaine (Drug)

TQL saline (placebo)

Placebo Comparator

Bilateral single shot of saline 0.9% 30 mL. in Total 60 mL of saline 0.9%

干预措施: Saline (Drug)

结局指标

主要结局

opioid consumption

时间窗: 12 hours postoperatively

Opioid consumption postoperatively: data from Patient Controlled Analgesia(PCA) pump and patient medical record).

次要结局

  • opioid consumption(24 hours postoperatively)
  • NRS score(12 hours postoperatively)
  • NRS score at rest and activity(24 hours postoperatively)
  • Opioid-related side effects(24 hours postoperatively)
  • Patient satisfaction with application of the block. NRS(Immediately after application of the block)
  • Ambulation(within 24 hours postoperatively)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Ultrasound-guided Transmuscular Quadratus Lumborum... | 临床试验